Skip to main content

Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q3 2022

Institutional positions in Amicus Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
222
+12 vs. Q2 2022
Shares held
292.4M
−12.8M (−4.2%) vs. Q2 2022
Total value
$3.05B
−$229.0M (−7.0%) vs. Q2 2022
New holders
34
73 more added
Sold out
22
72 more reduced

3 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FOLD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 222 institutions
Q1 2021: 259 institutionsQ2 2021: 235 institutionsQ3 2021: 238 institutionsQ4 2021: 224 institutionsQ1 2022: 216 institutionsQ2 2022: 213 institutionsQ3 2022: 222 institutionsQ4 2022: 230 institutionsQ1 2023: 226 institutionsQ2 2023: 216 institutionsQ3 2023: 229 institutionsQ4 2023: 229 institutionsQ1 2024: 254 institutionsQ2 2024: 259 institutionsQ3 2024: 293 institutionsQ4 2024: 290 institutionsQ1 2025: 286 institutionsQ2 2025: 272 institutionsQ3 2025: 287 institutionsQ4 2025: 332 institutionsQ1 2026: 298 institutionsQ2 2026: 2 institutions
Value heldQ3 2022: $3.05B
Q1 2021: $2.74BQ2 2021: $2.67BQ3 2021: $2.80BQ4 2021: $3.48BQ1 2022: $2.87BQ2 2022: $3.28BQ3 2022: $3.05BQ4 2022: $3.57BQ1 2023: $3.30BQ2 2023: $3.86BQ3 2023: $3.63BQ4 2023: $4.53BQ1 2024: $3.79BQ2 2024: $3.13BQ3 2024: $3.31BQ4 2024: $2.88BQ1 2025: $2.55BQ2 2025: $1.83BQ3 2025: $2.46BQ4 2025: $4.57BQ1 2026: $4.81BQ2 2026: $11.5K
Institutions holding FOLD and their total value by quarter
QuarterHoldersValue
Q2 20262$11.5K
Q1 2026298$4.81B
Q4 2025332$4.57B
Q3 2025287$2.46B
Q2 2025272$1.83B
Q1 2025286$2.55B
Q4 2024290$2.88B
Q3 2024293$3.31B
Q2 2024259$3.13B
Q1 2024254$3.79B
Q4 2023229$4.53B
Q3 2023229$3.63B
Q2 2023216$3.86B
Q1 2023226$3.30B
Q4 2022230$3.57B
Q3 2022222$3.05B
Q2 2022213$3.28B
Q1 2022216$2.87B
Q4 2021224$3.48B
Q3 2021238$2.80B
Q2 2021235$2.67B
Q1 2021259$2.74B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Amicus Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding FOLD in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Daiwa Securities Group Inc.1,044$11.0K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.980$10.0K0.00%−146−13.0%Reduced
Hazlett, Burt & Watson, Inc.1,000$10.0K0.01%00.0%Unchanged
TCI Wealth Advisors, Inc.666$7.00K0.00%00.0%Unchanged
Crewe Advisors LLC610$6.00K0.00%00.0%Unchanged
Baillie Gifford & Co538$6.00K0.00%00.0%Unchanged
High Net Worth Advisory Group LLC500$5.00K0.00%00.0%Unchanged
Lindbrook Capital, LLC461$5.00K0.00%+339+277.9%Added
Whittier Trust Co356$4.00K0.00%00.0%Unchanged
Wipfli Financial Advisors LLC,358$4.00K0.00%+358New
C M Bidwell & Associates Ltd215$2.00K0.00%−60−21.8%Reduced
Bell Investment Advisors, Inc222$2.00K0.00%00.0%Unchanged
Harvest Group Wealth Management, LLC140$2.00K0.00%+5+3.7%Added
Capital Advisors, Ltd. LLC166$2.00K0.00%+166New
Signaturefd, LLC81$1.00K0.00%00.0%Unchanged
Key Financial Inc100$1.00K0.00%00.0%Unchanged
Rise Advisors, LLC58$1.00K0.00%00.0%Unchanged
Ten Capital Wealth Advisors, LLC85$1.00K0.00%+10+13.3%Added
Newbridge Financial Services Group, Inc.95$1.00K0.00%00.0%Unchanged
Allworth Financial LP84$1.00K0.00%+61+265.2%Added
Huntington National Bank1$00.00%00.0%Unchanged
Valley National Advisers Inc20$00.00%00.0%Unchanged
Adage Capital Partners GP, L.L.C.0$00.00%−848,157−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−753,037−100.0%Sold out
Eversept Partners, LP0$00.00%−478,245−100.0%Sold out
Connor, Clark & Lunn Investment Management Ltd.0$00.00%−110,652−100.0%Sold out
Jennison Associates LLC0$00.00%−65,788−100.0%Sold out
American Century Companies Inc0$00.00%−49,340−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−47,952−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−34,639−100.0%Sold out
Guggenheim Capital LLC0$00.00%−32,199−100.0%Sold out
Trexquant Investment LP0$00.00%−27,077−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−26,399−100.0%Sold out
Squarepoint Ops LLC0$00.00%−12,500−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−12,023−100.0%Sold out
Gotham Asset Management, LLC0$00.00%−11,561−100.0%Sold out
Patriot Financial Group Insurance Agency, LLC0$00.00%−1,205−100.0%Sold out
Antonetti Capital Management LLC0$00.00%−900−100.0%Sold out
Captrust Financial Advisors0$00.00%−248−100.0%Sold out
Moisand Fitzgerald Tamayo, LLC0$00.00%−100−100.0%Sold out
FourThought Financial, LLC0$00.00%−118−100.0%Sold out
Canada Pension Plan Investment Board0$00.00%−10−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−28−100.0%Sold out
International Biotechnology Trust PLC0$00.00%−1,017−100.0%Sold out
Fieldpoint Private Securities, LLC––––Not filed
Cordasco Financial Network––––Not filed
Exane Derivatives––––Not filed